Hanseatic Management Services »

Halozyme Therapeutics shares owned by Hanseatic Management Services

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Hanseatic Management Services from 13F filings

Historical chart of Hanseatic Management Services investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Hanseatic Management Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Hanseatic Management Services

Quarter filed Position value Share count Share price at filing
2012-03-31 $20k 1.5k 12.94

More positions owned by Hanseatic Management Services

iShares Liquidity Income Fund Etf (ICSH)
Invesco NASDAQ 100 ETF Etf (QQQM)
Schwab U.S. Large-Cap ETF Etf (SCHX)
Vertiv Holdings Llc vertiv holdings (VRT)
VanEck Vectors Semiconductor E Etf (SMH)
SPDR Utilities Select Etf (XLU)
NVIDIA Corporation (NVDA)
Schwab U.S. Small-Cap ETF Etf (SCHA)
Goldman Sachs Equal Weight US Etf (GSEW)
iShares North Amer Tech-Soft Etf (IGV)
Facebook Inc cl a (META)
Abercrombie & Fitch (ANF)
SPDR Cons Staples Slct Etf (XLP)
RadNet (RDNT)
Eli Lilly & Co. (LLY)

View all positions for Hanseatic Management Services

Top funds holding Halozyme Therapeutics

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Alliancebernstein
Artisan Partners Limited Partnership
Macquarie Group
Geode Capital Management
Jpmorgan Chase & Co
Congress Asset Management
Bank of America Corporation
Arrowpoint Asset Management
Handelsbanken Fonder AB
Invesco

View all funds holding Halozyme Therapeutics